ARCHIVES

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980

NCI “Can’t Justify Size Of Intramural Program”

May 12, 1995

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

August 12, 2011

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979